Research ArticleMolecular Imaging of Cancer: From Molecules to Humans
Multimodality Molecular Imaging of Tumor Angiogenesis
Weibo Cai and Xiaoyuan Chen
Journal of Nuclear Medicine June 2008, 49 (Suppl 2) 113S-128S; DOI: https://doi.org/10.2967/jnumed.107.045922
In this issue
Journal of Nuclear Medicine
Vol. 49, Issue Suppl 2
June 2008
Multimodality Molecular Imaging of Tumor Angiogenesis
Weibo Cai, Xiaoyuan Chen
Journal of Nuclear Medicine Jun 2008, 49 (Suppl 2) 113S-128S; DOI: 10.2967/jnumed.107.045922
Jump to section
- Article
- Abstract
- VEGF/VEGFRS
- RADIONUCLIDE-BASED IMAGING OF VEGF/VEGFR EXPRESSION
- NON–RADIONUCLIDE-BASED IMAGING OF VEGF/VEGFR EXPRESSION
- FUTURE DIRECTIONS FOR VEGF/VEGFR IMAGING
- INTEGRIN αVβ3
- RADIONUCLIDE-BASED IMAGING OF INTEGRIN αVβ3 EXPRESSION
- NON–RADIONUCLIDE-BASED IMAGING OF INTEGRIN αVβ3 EXPRESSION
- MULTIMODALITY IMAGING OF INTEGRIN αVβ3 EXPRESSION
- SUMMARY AND FUTURE PERSPECTIVES
- CONCLUSION
- Acknowledgments
- Footnotes
- References
- Figures & Data
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- PET Imaging of Receptor Tyrosine Kinases in Cancer
- Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer
- Molecular Imaging of Post-Src Inhibition Tumor Signatures for Guiding Dasatinib Combination Therapy
- Evaluation of multimodality imaging using image fusion with MRI and CEUS in an experimental animal model
- Noninvasive Imaging of Cardiovascular Injury Related to the Treatment of Cancer
- In Vivo Imaging of Neurovascular Remodeling After Stroke
- 99mTc-Labeled Tricarbonyl His-CNA35 as an Imaging Agent for the Detection of Tumor Vasculature
- Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications
- 18F-FPPRGD2 and 18F-FDG PET of Response to Abraxane Therapy
- VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment
- Current data on predictive markers for anti-angiogenic therapy in thoracic tumours